Latest Breaking News On - John smither - Page 1 : comparemela.com

Arcutis Biotherapeutics, Inc (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript

Arcutis Biotherapeutics, Inc (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLatha vairavanSerge belangerDavid topperSeamus fernandezFrank watanabeJohn smitherVikram purohitPatrick burnettArcutis biotherapeuticEmma guttmanTyler van burenPatrick burnetTodd edwardsArcutis biotherapeutics inc

Arcutis Appoints David Topper as Chief Financial Officer

Industry veteran with over 40 years of experience in finance, investment management, and investment bankingWESTLAKE VILLAGE, Calif., April 10, 2024 Arcutis Biotherapeutics, Inc. , a.

Amanda sheldonLatha vairavanFrank watanabeJohn smitherDavid topperDerek coleArcutis biotherapeutics incCommitments committeeFrazier life sciencesDuke universityFrazier life sciences acquisition corpInvestor relations advisory solutionsExchange commissionMorgan stanleyStanford universityHead of corporate communications

U12 schoolboys divisions promise thrills and spills

THE U12 schoolboys’ age-grade will be one of the many highlights of a new season of the 2024 SuperValu West Cork Schoolboys and Schoolgirls

Bantry bayJohn smitherEoghan foleyOliver kielyKilgoban fionn wisemanBryan brickleyEoin mccarthyEthan coughlanVittor coutinhoCastlelack hibsRua murphyEoghain hollandBlake hegartyTiernan creweBen mackeyMax bramoulle

Form S-8 GENELUX Corp

Form S-8 GENELUX Corp
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWestlake villageSan diegoState of californiaJamesl tyreeLourie zakJasonl kentThomas zindrickChristines kimJohn smitherMary mirabelliJohn thomasSecurities exchangeGenelux corporationExchange commission onGenelux corporation the registrant

Arcutis Biotherapeutics, Inc (NASDAQ:ARQT) Q4 2023 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.72 EPS, expectations were $-0.65. Arcutis Biotherapeutics, Inc.

United statesSean kimVikram purohitTyler van burenSeamus fernandezFrank watanabeJohn smitherChris shibutaniSerge belangerPatrick burnettArcutis biotherapeuticTodd edwardsDerek coleArcutis biotherapeutics incGoldman sachsTrademark office